Hopkins Biotech offentlig
[search 0]
Mer

Download the App!

show episodes
 
Loading …
show series
 
Dr. Phil Kantoff is the CEO and Co-Founder of Convergent Therapeutics, a clinical-stage pharmaceutical company focused on developing next-generation radiopharmaceutical therapies for prostate and other cancers. The company's proprietary technology involves dual-targeted radionuclide therapy developed by Dr. Neil Bander, Professor of Urologic Oncolo…
 
Dr. Steve Doberstein has had a long career leading Research groups at a number of biotech companies, like “XOMA”- a monoclonal antibody discovery and development company, “Five Prime Therapeutics”- a protein and antibody discovery and development company, “Xencor”- a leader in protein engineering and “Exelixis”-a genomics-based drug discovery compa…
 
Dr. Daniel Elgort currently serves as the Chief Data and Analytics Officer for M2GEN, a bioinformatics company focused on the acceleration of oncology research discoveries through superior data and analytics services. The company was formed as a spin-off of the Moffitt Cancer Center in Tampa, Florida, serving as the technological hub for an allianc…
 
Hong Tang is the co-founder and Chief Medical Officer of OnQuality Pharmaceuticals, a targeted cancer supportive care (TCSC) pharmaceutical company dedicated to the development of treatments to address specific side effects of cancer therapies- to improve the quality of life and outcomes for patients fighting cancer. Prior to founding OnQuality, sh…
 
Laura Jacoby is currently an Application Specialist at Apprentice.io, an innovative tech company that offers cloud-based solutions that impact pharmaceutical production at every stage of development. Their goal is to introduce digitization of records in an industry that until recently has operated mainly in a paper and pen world. Laura has a career…
 
Alex Harding is a Senior Vice President of Business Development and Corporate Strategy at Remix Therapeutics, a Boston-based biotech company developing small molecules that alter RNA processing prior to protein translation. Their REMaster platform “enables the design of molecules that can selectively degrade RNA, enhance RNA expression, induce exon…
 
The crab season is here! If you are a Baltimore resident, you might have enjoyed dozens of our famous blue crabs, perhaps dozens of dozens every year. If you are new to Baltimore, you must have been encouraged to try them. Blue crabs are indeed tasty, but other than their nice savor, what do we know about them? This week on Sci'more podcast, crab b…
 
Our episode features two leaders at the global specialty pharmaceutical company Kyowa Kirin. Kyowa Kirin has a particular focus on the discovery and development of novel, first-in-class medicines that have a profound impact on patients in multiple therapeutic areas. Rachel Soloff is an executive director of research with expertise in immunology and…
 
McKane is a 5th year PhD student in the Department of Population, Family and Reproductive Health at Johns Hopkins Bloomberg School of Public Health She is conducting her PhD project under supervision of Dr. Terri Powell (https://www.researchbypowell.com/) trying to identify how multiple levels of support interact to influence positive sexual health…
 
Dr. Michael Nedelcovych is a Vice President of Equity Research at Cowen Inc., a diversified financial services firm that operates as a broker dealer and investment manager. Mike works on the large cap pharma equity research team – covering large, multinational pharmaceutical organizations – evaluating the performance of those companies in order to …
 
Eric Vivier is an SVP, CSO, and co-founder of Innate Pharma, a company developing innovative immunotherapy approaches with the goal of eradicating solid and metastatic tumors in the body. Eric is a Doctor of Veterinary Medicine (DVM) from the Ecole Nationale Vétérinaire de Maisons-Alfort and holds a Ph.D. in Immunology from the Paris University (Pa…
 
Dr. Michelle Ols is a Director and the Head of Cell Therapy at Obsidian Therapeutics. Obsidian Therapeutics is a private, Cambridge-based biotech company focused on the development of engineered cell and gene therapies for a range of indications. Obsidian has also pioneered their proprietary cytoDRiVE™ technology platform that leverages drug-respon…
 
Peter is a 5th-year PhD student from the Pathobiology program at Johns Hopkins School of medicine. As part of Dr. Laura D. Wood’s lab, his thesis is focused on to understanding new mechanisms of invasion of pancreatic cancer by using patient derived samples in organoid models. The decision to follow the Academic or Industry path has been always in …
 
Marisa is a fourth-year PhD candidate at the Johns Hopkins University School of Medicine in the Laboratory of Dr. Drew Pardoll. After her undergrad, she worked as a technician in industry for almost 6 years before deciding to go back to Academia to Pursue a PhD. Her thesis involves studying the role of AMPA receptors in T cells in the context of au…
 
Dr. Greg Verdine is an eminent serial entrepreneur and investor in the life sciences industry. He has founded a number of companies and currently serves as President, CEO, and CSO of both Fog Pharma and LifeMine Therapeutics. Greg also worked in the venture capital industry as a Venture Partner with Apple Tree Partners, Third Rock Ventures, WuXi He…
 
Beyond the Horizons is a mini podcast series about different career paths and relevant professional development topics to discover what lies beyond. Join Ken Igarza (MS Neuroscience), to learn more about his career journey as a NSF-GRFP Graduate Researcher. Hosted by Ona Ambrozaite, Chemistry Ph.D. candidate at Johns Hopkins University, Co-Chair fo…
 
Beyond the Horizons is a mini podcast series about different career paths and relevant professional development topics to discover what lies beyond. Join Dr. Samantha Black (PhD Nutrition Sciences), Editor-in-Chief at Science Board, to learn more about careers in writing and publishing. Hosted by Marta Sliwa, Chemistry Ph.D. candidate at Johns Hopk…
 
Beyond the Horizons is a mini podcast series about different career paths and relevant professional development topics to discover what lies beyond. Join Dr. Smiti Nathan (PhD Anthropology), Senior User Experience Researcher, to learn more about careers in UX Research. Hosted by Dr. Roshni Rao, Director of PHutures at Johns Hopkins University. Brou…
 
Beyond the Horizons is a mini podcast series about different career paths and relevant professional development topics to discover what lies beyond. Join Dr. Abeer Saha (PhD History), Curator at the National Museum of American History, to learn more about careers in museums. Hosted by Dr. Christine Kelly, Associate Director of PHutures at Johns Hop…
 
Wei-Chiang Chen, PhD is an Associate Director of Bioprocess Analytics in the Genome Medicine Unit at Sanofi, developing cell and gene therapies for areas of high unmet need. Prior to joining Sanofi, Wei-Chiang held positions at several large and small biotech companies including Biogen, Solid Biosciences, and Flexion Therapeutics. Additionally, he …
 
Dave is the CEO and Chief Scientific Officer of BioPhy, a healthcare fintech company committed to enhancing outcomes for patients and creating value for investors using their proprietary AI technology. Prior to starting BioPhy with his co-founders at the The Wharton School at the University of Pennsylvania where he received his MBA, Dave was a Seni…
 
Soufiane Aboulhouda is the co-founder and co-president of Nucleate, a new, student-run, non-profit activator program for the next generation of biotech founders. The mission of Nucleate is to train graduate students (PhDs, MBAs, Post-Docs, JDs, MDs, and Master’s) in company creation through a world-class network of advisors plus access to education…
 
Joe is a fourth-year PhD candidate at the Johns Hopkins University School of Medicine in the Laboratory of Dr. J.N. and R.F. Siliciano. If you are a Hopkins Biotech Podcast follower, you know Joe as the podcast co-director, producer and host. This time we have the pleasure to have him as a guest and to know more about his exciting career. His PhD t…
 
C.G. Moore, Ph.D., J.D., is a Partner at McBee Moore Woodward & Vanik IP, LLC., a boutique law firm based in Alexandria, Virginia, that specializes in intellectual property management in biotech, pharma, medical devices, and other life sciences-related industries. In this episode, C.G. describes his career path from experiencing the patenting proce…
 
Gian is a fourth-year PhD candidate at the Johns Hopkins University School of Medicine in the Solomon H. Snyder Department of Neuroscience. His thesis under the supervision of Dr. Dwight Bergles focuses on studying the dynamics and functional significance of cortical remyelination in diverse mouse models of multiple sclerosis. Gian is a Senior Fell…
 
Christy Wyskiel is the Senior Advisor to the President of Johns Hopkins University for Innovation & Entrepreneurship and the Executive Director of Johns Hopkins Technology Ventures. JHTV is the division of the university responsible for technology transfer, industry research partnerships, and startup acceleration under the brand ‘FastForward.’ Prio…
 
Ben Portney, Ph.D. is a Senior Associate at Flagship Pioneering, a life sciences venture capital firm specializing in company creation for transformational technologies. Ben is an entrepreneur-scientist, having previously worked in several ventures during his time as a graduate student including NSF I-Corps, an equity research externship at T. Rowe…
 
Patricia Phelps, PhD is the Associate Director of Academic Career Services at the Johns Hopkins School of Medicine, where she oversees professional development training for graduate students and postdocs. Pat has had an extensive career in biomedical PhD career training, previously serving as the Associate Director for the Professional Development …
 
Caroline Loew, Ph.D. is the President and CEO of Glympse Bio, an MIT spin out company trying to change the paradigm of in vivo diagnostic and prognostic monitoring for a wide range of disease indications. Prior to running Glympse Bio, Caroline held a number of high-level positions within some of the top global pharmaceutical companies including Mer…
 
Sam Semenkow, Ph.D. is a Director of Portfolio Intelligence at Bridge Bio, a unique biotechnology company that develops drugs in several modalities for a number of diverse disease areas. Prior to joining Bridge Bio, Sam was an Associate in the equity research group at Citi, a multinational bank. As an equity research associate, Sam covered a number…
 
Carina Clingman, PhD is a Principal and Founder of Recruitomics Biotalent Consulting, a biotechnology hiring and recruitment agency based in Cambridge, MA. Carina originally trained as a biochemist, earning her PhD in Biochemistry and Molecular Pharmacology from the University of Massachusetts Medical School. At Recruitomics, she leverages her expe…
 
In this episode, members of the Johns Hopkins Alternative Protein Project - Norah Sadowski, Lauren Blake, Mackenzie Simon-Collins, Mc Millan Ching, Jacquelyn Bedsaul, and Christine Wang- discuss a nontraditional application of biotech: alternative proteins. We explore the motivations, basic principles, challenges, and risks behind alternative prote…
 
Paul Yourik, Ph.D., is a Scientist at Moderna, a pioneering mRNA technology platform company specializing in vaccine and therapeutic development for a range of disease areas. Prior to Moderna, Paul received his Ph.D. in Biochemistry, Cellular, and Molecular Biology at the Johns Hopkins School of Medicine, training as an RNA biochemist. He later com…
 
Dr. Cristoph Lengauer Ph.D MBA is a Partner at Third Rock Ventures, an innovative venture capital firm focused on company creation, and supporting entrepreneurs from idea to discovery to the clinic. In this episode, Dr. Lengauer discusses Third Rock’s unique approach to venture funding, common sources of company ideation, and his path from the Care…
 
John Valliere-Douglass is the Associate Director and Mass Spectrometry Core Group Leader at Seagen (formerly, Seattle Genetics). John works in the Analytical Sciences division within Seagen’s development arm, using proteomics techniques to scale and manufacture therapeutic modalities in significant quantities to support clinical trials. Seagen is m…
 
Helena Zec, PhD is an Engagement Manager at Clearview Healthcare Partners, a leader in the life science and healthcare consulting space. Helena has held consulting roles at other well-known firms and holds a Ph.D. in Biomedical Engineering from the Johns Hopkins School of Medicine. In this episode, Helena shares her experience working in life scien…
 
Cindy Hoots is the Chief Digital Officer and CIO at AstraZeneca, a world leader in biopharmaceutical drug development. Cindy shares her thoughts on how the digital revolution will impact every aspect of drug development from R&D to clinical testing to delivery to patients. Hosted by Farai Sikipa.Av Hopkins Biotech Podcast
 
Nick Edwards, PhD is currently the Chief of Staff to the CSO at Resilience, a privately-held manufacturing and technology company devoted to building a sustainable and accessible biopharmaceutical supply chain. When we interviewed Nick, he was working in the Global Sales Operations division of Illumina, an American public biotech company that manuf…
 
Michael Kauffman, MD/PhD is the Founder & CEO of Karyopharm, a pharmaceutical company that develops & commercializes various drugs directed against nuclear export and related targets for the treatment of cancer, inflammation, viral diseases, and other disorders of proliferation. Michael is a seasoned pharmaceutical executive, having also served as …
 
Peter Kolchinsky, PhD, is a Managing Partner at RA Capital Management, a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and life science companies developing drugs, medical devices, and diagnostics. He additionally serves on the board of several public and private life science companies. Additi…
 
Vania Cao, Ph.D is the Founder of Free The PhD, an educational platform designed to help late-stage STEM PhDs successfully break into the job market. Vania shares how graduate students can best position themselves for management consulting or other business careers, strike a balance between career satisfaction & income level, and make career transi…
 
Michael Ehlers, MD/PhD, is the CSO and Venture Partner at Apple Tree Partners, a life sciences venture capital firm that creates and invests in biotech companies at various stages, from pre-seed, through to IPO and beyond. He additionally serves as the CEO of Limelight Bio and the President & Executive Chair of Aulos Bioscience, two biotech startup…
 
In this episode, an esteemed panel of four from Bain & Company - Bobbi Lambros (Recruiting Manager, North America), Amir Niaki (Consultant, DC), Nik Hoffman (Consultant, DC), and Jackie Flanagan (Associate Partner, DC - shares Bain's interview process & evaluation strategy, walks us through a sample case, and talks about applying to Bain. Hosted by…
 
Miranda Broz, PhD is the Scientific Associate Director of Discovery Myeloid Biology at Bristol Myers Squibb’s R&D site in Redwood City, California. Miranda and her team explores parts of the tumor microenvironment (TME) - including regulatory T cells, stromal cells and myeloid antigen presenting cells - to develop novel treatment options that will …
 
Melissa Stundick, PhD is the VP of Business Development at Spero Therapeutics, a clinical-stage biotech company that develops treatments for multidrug-resistant bacterial infections. In this episode, Melissa shares her journey from PhD to Lead Associate at the consulting firm Booz Allen Hamilton to Chief of the Anti-Infectives Program at BARDA to h…
 
Jo Bhakdi is the Founder & CEO of Quantgene, an early-stage medical technology company that deploys machine learning & advanced genetic sequencing technologies to detect cancer at early stages of development. In 2016, they launched one of the largest clinical trials to assess the feasibility of cell-free DNA technology, with the goal of collecting …
 
This episode is part of the Boston Biotech Series - produced in collaboration with the Professional Development & Career Office (PDCO) at the Johns Hopkins School of Medicine. We encourage JHU students to join the online Boston Biotech Community on the OneHop platform to connect with the podcast’s guests as well as other JHU alumni who work in Bost…
 
Jeff Galvin is the CEO & Founder of American Gene Technologies (AGT), a clinical-stage biotech company with a proprietary gene-delivery platform for rapid development of cell and gene therapies to cure infectious diseases, cancers, and inherited disorders. He earned his BA degree in Economics from Harvard in 1981 and accumulated more than 30 years …
 
Dr. Paul Hergenrother, PhD is a Professor of Chemistry at the University of Illinois at Urbana-Champaign (UIUC), whose organic chemistry lab characterizes natural products to identify novel cellular targets and formulate treatments for cancer & drug-resistant bacteria. He along with Dr. Martin Burke and other UIUC staff led the effort undertaken at…
 
Bijal Trivedi, MS is an award-winning journalist and author of Breath from Salt, a book about the history of cystic fibrosis (CF). Breath from Salt is a story of a breakthrough in modern medicine that chronicles the discovery & characterization of the cystic fibrosis, the formation of the Cystic Fibrosis Foundation and how their unprecedented colla…
 
Loading …

Hurtigreferanseguide

Copyright 2022 | Sitemap | Personvern | Vilkår for bruk
Google login Twitter login Classic login